REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 105 filers reported holding REVANCE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.89 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $350,399 | -41.7% | 136,347 | +11.6% | 0.00% | -100.0% |
Q1 2024 | $600,994 | -42.8% | 122,156 | +2.3% | 0.00% | 0.0% |
Q4 2023 | $1,050,012 | -22.3% | 119,457 | +1.4% | 0.00% | -50.0% |
Q3 2023 | $1,350,909 | -54.0% | 117,779 | +1.5% | 0.00% | -33.3% |
Q2 2023 | $2,936,618 | +85416.0% | 116,026 | +8.8% | 0.00% | -25.0% |
Q1 2023 | $3,434 | +81.2% | 106,611 | +3.9% | 0.00% | +33.3% |
Q4 2022 | $1,895 | -99.9% | 102,650 | +10.8% | 0.00% | -25.0% |
Q3 2022 | $2,501,000 | +116.9% | 92,638 | +11.0% | 0.00% | +100.0% |
Q2 2022 | $1,153,000 | -26.9% | 83,443 | +3.1% | 0.00% | 0.0% |
Q1 2022 | $1,578,000 | +18.4% | 80,902 | -0.9% | 0.00% | 0.0% |
Q4 2021 | $1,333,000 | -44.0% | 81,661 | -4.5% | 0.00% | -33.3% |
Q3 2021 | $2,381,000 | -2.6% | 85,476 | +3.7% | 0.00% | 0.0% |
Q2 2021 | $2,444,000 | -1.0% | 82,463 | -6.6% | 0.00% | 0.0% |
Q1 2021 | $2,469,000 | -9.1% | 88,329 | -7.8% | 0.00% | -25.0% |
Q4 2020 | $2,716,000 | +23.0% | 95,821 | +9.1% | 0.00% | +33.3% |
Q3 2020 | $2,208,000 | -11.4% | 87,813 | -14.0% | 0.00% | -25.0% |
Q2 2020 | $2,492,000 | +106.6% | 102,065 | +25.3% | 0.00% | +33.3% |
Q1 2020 | $1,206,000 | +9.4% | 81,468 | +20.0% | 0.00% | +50.0% |
Q4 2019 | $1,102,000 | +27.1% | 67,891 | +1.9% | 0.00% | 0.0% |
Q3 2019 | $867,000 | +5.5% | 66,654 | +5.1% | 0.00% | 0.0% |
Q2 2019 | $822,000 | +6.2% | 63,396 | +29.1% | 0.00% | +100.0% |
Q1 2019 | $774,000 | -11.2% | 49,124 | +13.3% | 0.00% | -50.0% |
Q4 2018 | $872,000 | +19.6% | 43,339 | +47.8% | 0.00% | +100.0% |
Q3 2018 | $729,000 | -15.5% | 29,328 | -6.8% | 0.00% | -50.0% |
Q2 2018 | $863,000 | +16.0% | 31,453 | +30.2% | 0.00% | 0.0% |
Q1 2018 | $744,000 | -2.2% | 24,166 | +13.6% | 0.00% | 0.0% |
Q4 2017 | $761,000 | +7.9% | 21,276 | -16.9% | 0.00% | 0.0% |
Q3 2017 | $705,000 | +5.4% | 25,603 | +1.1% | 0.00% | 0.0% |
Q2 2017 | $669,000 | +40.3% | 25,333 | +10.4% | 0.00% | +100.0% |
Q1 2017 | $477,000 | +9.9% | 22,938 | +9.3% | 0.00% | 0.0% |
Q4 2016 | $434,000 | +37.8% | 20,986 | +8.0% | 0.00% | 0.0% |
Q3 2016 | $315,000 | +21.6% | 19,430 | +2.1% | 0.00% | 0.0% |
Q2 2016 | $259,000 | -10.7% | 19,030 | +14.6% | 0.00% | 0.0% |
Q1 2016 | $290,000 | -47.0% | 16,610 | +3.7% | 0.00% | -50.0% |
Q4 2015 | $547,000 | +32.8% | 16,020 | +15.7% | 0.00% | +100.0% |
Q3 2015 | $412,000 | -3.1% | 13,850 | +4.1% | 0.00% | 0.0% |
Q2 2015 | $425,000 | +99.5% | 13,299 | +112.0% | 0.00% | 0.0% |
Q2 2014 | $213,000 | – | 6,274 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
PointState Capital LP | 438,200 | $11,568,000 | 0.13% |